Cargando…

Benign, Pathogenic and Copy Number Variations of Unknown Clinical Significance in Patients with Congenital Malformations and Developmental Delay

The high frequency (3.0-5.0%) of congenital anomalies (CA) and intellectual disabilities (IDs), make them a serious problem, responsible for a high percentage (33.0%) of neonatal mortality. The genetic cause remains unclear in 40.0% of cases. Recently, molecular karyotyping has become the most power...

Descripción completa

Detalles Bibliográficos
Autores principales: Mihaylova, M, Staneva, R, Toncheva, D, Pancheva, M, Hadjidekova, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596816/
https://www.ncbi.nlm.nih.gov/pubmed/28924535
http://dx.doi.org/10.1515/bjmg-2017-0010
_version_ 1783263607426908160
author Mihaylova, M
Staneva, R
Toncheva, D
Pancheva, M
Hadjidekova, S
author_facet Mihaylova, M
Staneva, R
Toncheva, D
Pancheva, M
Hadjidekova, S
author_sort Mihaylova, M
collection PubMed
description The high frequency (3.0-5.0%) of congenital anomalies (CA) and intellectual disabilities (IDs), make them a serious problem, responsible for a high percentage (33.0%) of neonatal mortality. The genetic cause remains unclear in 40.0% of cases. Recently, molecular karyotyping has become the most powerful method for detection of pathogenic imbalances in patients with multiple CAs and IDs. This method is with high resolution and gives us the opportunity to investigate and identify candidate genes that could explain the genotype-phenotype correlations. This article describes the results from analysis of 81 patients with congenital malformations (CMs), developmental delay (DD) and ID, in which we utilized the CytoChip ISCA oligo microarray, 4 × 44 k, covering the whole genome with a resolution of 70 kb. In the selected group of patients with CAs, 280 copy number variations (CNVs) have been proven, 41 were pathogenic, 118 benign and 121 of unknown clinical significance (average number of variations 3.5). In six patients with established pathogenic variations, our data revealed eight pathogenic aberrations associated with the corresponding phenotype. The interpretation of the other CNVs was made on the basis of their frequency in the investigated group, the size of the variation, content of genes in the region and the type of the CNVs (deletion or duplication).
format Online
Article
Text
id pubmed-5596816
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-55968162017-09-18 Benign, Pathogenic and Copy Number Variations of Unknown Clinical Significance in Patients with Congenital Malformations and Developmental Delay Mihaylova, M Staneva, R Toncheva, D Pancheva, M Hadjidekova, S Balkan J Med Genet Original Article The high frequency (3.0-5.0%) of congenital anomalies (CA) and intellectual disabilities (IDs), make them a serious problem, responsible for a high percentage (33.0%) of neonatal mortality. The genetic cause remains unclear in 40.0% of cases. Recently, molecular karyotyping has become the most powerful method for detection of pathogenic imbalances in patients with multiple CAs and IDs. This method is with high resolution and gives us the opportunity to investigate and identify candidate genes that could explain the genotype-phenotype correlations. This article describes the results from analysis of 81 patients with congenital malformations (CMs), developmental delay (DD) and ID, in which we utilized the CytoChip ISCA oligo microarray, 4 × 44 k, covering the whole genome with a resolution of 70 kb. In the selected group of patients with CAs, 280 copy number variations (CNVs) have been proven, 41 were pathogenic, 118 benign and 121 of unknown clinical significance (average number of variations 3.5). In six patients with established pathogenic variations, our data revealed eight pathogenic aberrations associated with the corresponding phenotype. The interpretation of the other CNVs was made on the basis of their frequency in the investigated group, the size of the variation, content of genes in the region and the type of the CNVs (deletion or duplication). De Gruyter 2017-06-30 /pmc/articles/PMC5596816/ /pubmed/28924535 http://dx.doi.org/10.1515/bjmg-2017-0010 Text en © 2017 Walter de Gruyter GmbH, Berlin/Boston
spellingShingle Original Article
Mihaylova, M
Staneva, R
Toncheva, D
Pancheva, M
Hadjidekova, S
Benign, Pathogenic and Copy Number Variations of Unknown Clinical Significance in Patients with Congenital Malformations and Developmental Delay
title Benign, Pathogenic and Copy Number Variations of Unknown Clinical Significance in Patients with Congenital Malformations and Developmental Delay
title_full Benign, Pathogenic and Copy Number Variations of Unknown Clinical Significance in Patients with Congenital Malformations and Developmental Delay
title_fullStr Benign, Pathogenic and Copy Number Variations of Unknown Clinical Significance in Patients with Congenital Malformations and Developmental Delay
title_full_unstemmed Benign, Pathogenic and Copy Number Variations of Unknown Clinical Significance in Patients with Congenital Malformations and Developmental Delay
title_short Benign, Pathogenic and Copy Number Variations of Unknown Clinical Significance in Patients with Congenital Malformations and Developmental Delay
title_sort benign, pathogenic and copy number variations of unknown clinical significance in patients with congenital malformations and developmental delay
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596816/
https://www.ncbi.nlm.nih.gov/pubmed/28924535
http://dx.doi.org/10.1515/bjmg-2017-0010
work_keys_str_mv AT mihaylovam benignpathogenicandcopynumbervariationsofunknownclinicalsignificanceinpatientswithcongenitalmalformationsanddevelopmentaldelay
AT stanevar benignpathogenicandcopynumbervariationsofunknownclinicalsignificanceinpatientswithcongenitalmalformationsanddevelopmentaldelay
AT tonchevad benignpathogenicandcopynumbervariationsofunknownclinicalsignificanceinpatientswithcongenitalmalformationsanddevelopmentaldelay
AT panchevam benignpathogenicandcopynumbervariationsofunknownclinicalsignificanceinpatientswithcongenitalmalformationsanddevelopmentaldelay
AT hadjidekovas benignpathogenicandcopynumbervariationsofunknownclinicalsignificanceinpatientswithcongenitalmalformationsanddevelopmentaldelay